中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021

2021-12-25 中国临床肿瘤学会指南工作委员会肿瘤预防与治疗

基于循证医学证据、兼顾诊疗产品的可及性、吸收精准医学新进展,制定中国常见癌症的诊断和治疗指南,是中国临床肿瘤学会(CSCO)的基本任务之一。

中文标题：

发布机构：

中国临床肿瘤学会指南工作委员会

发布日期：

2021-12-25

简要介绍：

基于循证医学证据、兼顾诊疗产品的可及性、吸收精准医学新进展,制定中国常见癌症的诊断和治疗指南,是中国临床肿瘤学会(CSCO)的基本任务之一。近年来,临床诊疗指南的制定出现新的趋向,即基于诊疗资源的可及性,这尤其适合发展中或地区差异性显著的国家和地区。中国是幅员辽阔,地区经济和学术发展不平衡的发展中国家,CSCO指南需要兼顾地区发展差异、药物和诊疗手段的可及性以及肿瘤治疗的社会价值三个方面。因此,CSCO指南的制定,要求每一个临床问题的诊疗意见,需根据循证医学证据和专家共识度形成证据类别,同时结合产品的可及性和效价比形成推荐等级。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=89d491c0023a54a6, title=中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021, enTitle=, guiderFrom=肿瘤预防与治疗, authorId=0, author=, summary=基于循证医学证据、兼顾诊疗产品的可及性、吸收精准医学新进展,制定中国常见癌症的诊断和治疗指南,是中国临床肿瘤学会(CSCO)的基本任务之一。, cover=https://img.medsci.cn/202223/1643855954876_5579292.png, journalId=0, articlesId=null, associationId=1983, associationName=中国临床肿瘤学会指南工作委员会, associationIntro=中国临床肿瘤学会指南工作委员会, copyright=0, guiderPublishedTime=Sat Dec 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">基于循证医学证据、兼顾诊疗产品的可及性、吸收精准医学新进展,制定中国常见癌症的诊断和治疗指南,是中国临床肿瘤学会(CSCO)的基本任务之一。近年来,临床诊疗指南的制定出现新的趋向,即基于诊疗资源的可及性,这尤其适合发展中或地区差异性显著的国家和地区。中国是幅员辽阔,地区经济和学术发展不平衡的发展中国家,CSCO指南需要兼顾地区发展差异、药物和诊疗手段的可及性以及肿瘤治疗的社会价值三个方面。因此,CSCO指南的制定,要求每一个临床问题的诊疗意见,需根据循证医学证据和专家共识度形成证据类别,同时结合产品的可及性和效价比形成推荐等级。 </span></p>, tagList=[TagDto(tagId=736, tagName=甲状腺), TagDto(tagId=865, tagName=甲状腺癌), TagDto(tagId=7891, tagName=分化型甲状腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7566, appHits=354, showAppHits=0, pcHits=1334, showPcHits=7210, likes=2, shares=73, comments=12, approvalStatus=1, publishedTime=Tue Feb 08 15:34:00 CST 2022, publishedTimeString=2021-12-25, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Feb 03 10:41:10 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 19:52:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021.pdf)])

中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021.pdf

下载请点击：

评论区 (10)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2088984, encodeId=4ec72088984c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Mon Sep 19 09:52:52 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224648, encodeId=17951224648af, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL2qEM6CTdm3icd2KY7AuDAIEGH9kvcbHQVhibnLuFbf2MhzKqEyib3AribelLfBaS87mibR7YtJdc4JrA/132, createdBy=9dbc5307831, createdName=docyyx, createdTime=Sun Jun 05 23:33:48 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209403, encodeId=ce10120940370, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdeb5452533, createdName=ms5000000777054870, createdTime=Thu Apr 07 23:14:02 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200936, encodeId=514b120093647, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=776d5519902, createdName=ms2000001051871447, createdTime=Wed Mar 09 16:51:55 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195412, encodeId=762411954124f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d05a5574909, createdName=ms7000000909951304, createdTime=Sun Feb 20 18:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
2022-09-19 1471d48dm72暂无昵称

学习了

76 0
[GetPortalCommentsPageByObjectIdResponse(id=2088984, encodeId=4ec72088984c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Mon Sep 19 09:52:52 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224648, encodeId=17951224648af, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL2qEM6CTdm3icd2KY7AuDAIEGH9kvcbHQVhibnLuFbf2MhzKqEyib3AribelLfBaS87mibR7YtJdc4JrA/132, createdBy=9dbc5307831, createdName=docyyx, createdTime=Sun Jun 05 23:33:48 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209403, encodeId=ce10120940370, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdeb5452533, createdName=ms5000000777054870, createdTime=Thu Apr 07 23:14:02 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200936, encodeId=514b120093647, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=776d5519902, createdName=ms2000001051871447, createdTime=Wed Mar 09 16:51:55 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195412, encodeId=762411954124f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d05a5574909, createdName=ms7000000909951304, createdTime=Sun Feb 20 18:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
2022-06-05 docyyx

实用

89 0
[GetPortalCommentsPageByObjectIdResponse(id=2088984, encodeId=4ec72088984c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Mon Sep 19 09:52:52 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224648, encodeId=17951224648af, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL2qEM6CTdm3icd2KY7AuDAIEGH9kvcbHQVhibnLuFbf2MhzKqEyib3AribelLfBaS87mibR7YtJdc4JrA/132, createdBy=9dbc5307831, createdName=docyyx, createdTime=Sun Jun 05 23:33:48 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209403, encodeId=ce10120940370, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdeb5452533, createdName=ms5000000777054870, createdTime=Thu Apr 07 23:14:02 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200936, encodeId=514b120093647, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=776d5519902, createdName=ms2000001051871447, createdTime=Wed Mar 09 16:51:55 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195412, encodeId=762411954124f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d05a5574909, createdName=ms7000000909951304, createdTime=Sun Feb 20 18:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
2022-04-07 ms5000000777054870

值得学习

96 0
[GetPortalCommentsPageByObjectIdResponse(id=2088984, encodeId=4ec72088984c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Mon Sep 19 09:52:52 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224648, encodeId=17951224648af, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL2qEM6CTdm3icd2KY7AuDAIEGH9kvcbHQVhibnLuFbf2MhzKqEyib3AribelLfBaS87mibR7YtJdc4JrA/132, createdBy=9dbc5307831, createdName=docyyx, createdTime=Sun Jun 05 23:33:48 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209403, encodeId=ce10120940370, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdeb5452533, createdName=ms5000000777054870, createdTime=Thu Apr 07 23:14:02 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200936, encodeId=514b120093647, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=776d5519902, createdName=ms2000001051871447, createdTime=Wed Mar 09 16:51:55 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195412, encodeId=762411954124f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d05a5574909, createdName=ms7000000909951304, createdTime=Sun Feb 20 18:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
2022-03-09 ms2000001051871447

学习

92 0
[GetPortalCommentsPageByObjectIdResponse(id=2088984, encodeId=4ec72088984c4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Mon Sep 19 09:52:52 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224648, encodeId=17951224648af, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL2qEM6CTdm3icd2KY7AuDAIEGH9kvcbHQVhibnLuFbf2MhzKqEyib3AribelLfBaS87mibR7YtJdc4JrA/132, createdBy=9dbc5307831, createdName=docyyx, createdTime=Sun Jun 05 23:33:48 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209403, encodeId=ce10120940370, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdeb5452533, createdName=ms5000000777054870, createdTime=Thu Apr 07 23:14:02 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200936, encodeId=514b120093647, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=776d5519902, createdName=ms2000001051871447, createdTime=Wed Mar 09 16:51:55 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195412, encodeId=762411954124f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d05a5574909, createdName=ms7000000909951304, createdTime=Sun Feb 20 18:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
2022-02-20 ms7000000909951304

学习了

100 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021

相关指南

科室

工具

服务